b12 with lipotropic injections 10 — WEEKLY Lipo-B Injection | Empower Pharmacy

Contraindications Given the limited safety data, conservative contraindications would include pregnancy or plans to become pregnant, breastfeeding, age under 18, severe liver or kidney disease, and any condition requiring medications with unknown interaction potential

This decrease is associated with the cessation of B12 injections at 6 weeks indicating injections may be effective only short-term

Although AOD 9604 does not affect blood sugar, people actively managing diabetes with medication should monitor more carefully when adding any new compound to their regimen

Confirm current FDA approval and trial status on FDA.gov and ClinicalTrials.gov before relying on this paragraph for planning